Study of EVO756 in Adults With Migraine
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Evommune, Inc.
- Study ID
- NCT07616128
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- EVO756, Dose 1 — DRUGOrally administered EVO756, Dose 1 (Daily)
- EVO756, Dose 2 — DRUGOrally administered EVO756, Dose 2 (Daily)
- Placebo — DRUGPlacebo Control (Daily)
Study Details
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Oct 31, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 330 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Dose 1Orally administered EVO756, Dose 1 (Daily)
- Experimental: Dose 2Orally administered EVO756, Dose 2 (Daily)
- Placebo Comparator: PlaceboPlacebo control (Daily)
Primary Outcome Measure
Mean change from baseline in the number of monthly migraine days (MMD) [ Time Frame: Last month of the 12-week treatment period ]
Central Contacts
- Nichole Baio(650) 319-4553
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CA Medical Clinic for Headache | Los Angeles | California | 90067 | |
| New England Institute for Neurology and Headache | Stamford | Connecticut | 06905 | |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | |
| Apple Medical Research Group, Inc | Miami | Florida | 331216 | |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32819 | (650) 319-4553 |
| Vantage Clinical Trials | Tampa | Florida | 33614 | |
| Accel Research Site-Decatur-Alcanza | Decatur | Georgia | 30030 | |
| Michigan Headache and Neurological Institute | Ann Arbor | Michigan | 48104 | |
| Clinosis - Dent Neurologic Instite | Amherst | New York | 14226 | |
| Eximia Research NC | Raleigh | North Carolina | 27607 | |
| Clinical Trials of South Carolina | Charleston | South Carolina | 29406 | |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | |
| FutureSearch Trials of Dallas | Dallas | Texas | 75251 | |
| Vaught Neurological Services | Crab Orchard | West Virginia | 25827 |
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Related Studies
- Pain Biomarker StudyPHASE1 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial PainPHASE2 · Recruiting · Stanford University · Stanford, California
- Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to RimegepantRecruiting · Pfizer · Wilmington, North Carolina
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama